key: cord-0804838-imlqzcwh
authors: Sharma, Manisha; Menon, Bindu
title: Headache Incidence and Characteristics in COVID-19 Patients: A Hospital-Based Study
date: 2021-11-29
journal: Ann Indian Acad Neurol
DOI: 10.4103/aian.aian_244_21
sha: d9a25c6c60f16f10f36da098f82877265d6a5192
doc_id: 804838
cord_uid: imlqzcwh

BACKGROUND: Headache is one of the commonly reported symptoms of coronavirus disease-2019 (COVID-19) illness. A number of studies have been done so far focusing on headache associated with COVID-19 with variable incidence and characteristics. MATERIAL AND METHODS: This study is a prospective study conducted on 120 patients with confirmed COVID-19 illness. Critically ill and ventilated patients were excluded. Demographic data, COVID illness symptom profile, headache characteristics were documented. Patients were followed up at 2 weeks and 4 weeks. For the statistical analysis, Statistical Package for the Social Sciences (SPSS), version 24.0 was used. RESULTS: 120 COVID-19 positive cases were included in the study with a mean age of 54.59 ± 14.89 years (range 21-84 years) with male-to-female ratio of 3:2. 78.33% (94) of patients had various comorbidities. 43.33% (52) cases were diabetic. The presenting symptoms were fever (65%), cough (53.33%), shortness of breath (35%) and myalgia (31.66%). 26 (21.66%) patients reported headache during the COVID illness. 18 (15%) cases had headache attributed as secondary to COVID-19 illness. Out of them, 12 cases were new onset with no past history of headache and 6 cases had a significant change in previous headache episodes. COVID-19 illness precipitated headache episodes similar to past headache type in 8 cases. Headache was the presenting symptom in 8 (6.66%) patients with COVID-19 being detected in the regular hospital screening protocol. CONCLUSION: Headache was a common symptom in COVID-19 patients. New onset headaches or change in past headache type in patients in the setting of ongoing pandemic should be screened for COVID-19.

increase in frequency and/or severity) in close temporal relation to COVID-19 illness. [4] All patients with a positive history of headache were followed for a period of 4 weeks telephonically after discharge from hospital. Calls were made at 2 weeks and 4 weeks. For the statistical analysis, Statistical Package for the Social Sciences (SPSS), version 24.0 was used and statistics included percentage, mean and standard deviation.

From June 2020 to December 2020, the hospital received 175 COVID-positive cases. 55 critically ill patients were excluded from the study. 120 COVID-19 positive cases were enrolled with a mean age of 54.59 ± 14.89 years (range 21 -84 years) and male-to-female ratio of 3:2. The detailed demographic profile and COVID symptomatology has been shown in Table 1 . The average COVID-19 reporting and data system (CO-RADS) score was 4.33 (range 0-5) with mean chest CT severity index of 8.03 (range 0-20). Comorbidities like hypertension, diabetes, coronary artery disease, obstructive lung disease, chronic kidney disease were present in 78.33% (94) of cases. 43.33% (52) cases were diabetic. There were three or more than three comorbidities in 11.66% (14) cases. One patient had newly retroviral state positive. The common symptoms were fever (65%), cough (53.33%), shortness of breath (35%), myalgia (31.66%) followed by headache (21.66%). Sore throat, diarrhoea, loss of smell/taste, and fatigue were less commonly reported. None of the patients had altered sensorium, neck rigidity or focal neurological deficit. 5% of cases were on oxygen support.

Out of 120 COVID-positive cases, 26 (21.66%) reported headache during COVID illness. Out of these, 12 cases reported new-onset headache without any past history of headache. Fourteen cases had a past history of headache (7 migraine headache, 2 tension-type headache, 2 sinusitis, 1 post-traumatic headache, 2 nonspecific headache types). Among these 14, 6 cases reported a change in their character of headache from their regular headaches. So overall, secondary headache due to COVID-19 illness was reported in 18 (15%) cases and in other 8 cases, COVID illness precipitated the headache episode of past headache type [ Figure 1 ].

Characteristics of secondary headache in 18 (15%) cases are given in Table 2 . Out of 18 secondary headache cases, 8 cases (6.66%) had headache as the first presenting symptom followed by fever (1-4 days interval range) and cough (1-8 days interval range). Location of headache was mostly bilateral in the temporal and frontal region. Headache was intermittent in all cases with variable duration of 30 minutes to 3 days. Onset was sudden as well as gradual with evening predilection. Headache was mild (mean visual analogue scale 2.76) vague dull aching type in most of the cases. The associated features reported were nausea, vomiting, phonophobia and photophobia. Cough was a common aggravating factor followed by stress and fever. The relieving factors reported were sleep and hot beverages. Brain imaging was not done in any case. All 18 patients were followed up telephonically for the next 1 month after discharge at 2 weeks and 4 weeks. There was complete headache relief in 8 out of 18 cases within hospital stay. Rest 10 cases were on painkillers when required and recovered within an average duration of 8.33 days after discharge. As per the international classification of headache disorders 3 rd edition (ICHD-3b), only 5 out of 18 cases fit into a classical headache phenotype. 3 cases had tension-type headache and 2 cases had migraine features. Rest 13 patients were not classified.

Headache attributed to infection (bacterial, viral, fungal, parasitic) is one of the important subgroup in the secondary headache category as per ICHD-3b. Intracranial infection as meningitis or meningoencephalitis as well as systemic infection can lead to headache. There should be a temporal relationship between headache and infection onset to establish the causal link. [4] Pathophysiologically, intracranial infections cause headache via direct meningeal infiltration, inflammatory effects of the products of bacteria and by inflammatory mediators. Whereas systemic infections like influenza cause irritation of pericranial or intracranial pain-sensitive structures by direct infiltration, release of endotoxins or the immune response of inflammatory mediators. Some organisms may trigger brainstem nuclei with the end result of neurogenic inflammation and headache. [5] COVID encephalitis has been reported in 6% of cases. [6] In this study, none of the patients had meningoencephalitis. All new-onset headaches or headaches with a significant change in past headache type had been attributed to systemic COVID illness in view of presence of definite temporal relation between the two.

In COVID-19 illness, headache has been reported in the category of "less common symptoms'' among the most prevalent ones like fever, fatigue, dry cough, myalgia and dyspnoea [7] which is consistent with this study. But it was alarming that 8 out of 18 new-onset headache cases had headache as the first and only manifestation of COVID illness. Fever and cough followed the headache by a duration of 4-8 days. In cases, headache preceded fever by 4 days and cough by 8 days. So in this pandemic era, any new-onset headache warrants low threshold for testing for COVID-19 resulting in early diagnosis before respiratory involvement to reduce the spread of infection.

Al-Hashel et al. reported 59.6% increase in migraine frequency and 64.1% increase in migraine severity during COVID era as compared to pre-pandemic period though only 4% migraine cases had COVID illness. The reasons are independent of COVID illness and multifactorial like poor follow up with neurologist, poor drug compliance, analgesic overuse, cancellation of botox sessions, poor sleep, anxiety and depression. [8, 9] Even mask-associated 'denovo' headache has been reported in 51.6 percent of healthcare workers. [10] So attributing COVID-19 as the causative factor to all headache types in COVID illness is probably not justified. Clinicians need to take the headache symptom in a broader perspective and consider other differentials even in the setting of COVID-19 illness. This study specifies that COVID illness-associated headache should be diagnosed in the setting of new-onset headache or change in past headache type in COVID illness with definite temporal relation between the two. COVID-19 associated headache has been frequently reported as mild to moderate intensity. [11] Uygun et al. 2020 found mild-and moderate-intensity headache in 74.3% vs severe and very severe headache in 25.7% COVID-19 positive patients. [12] Various classical headache phenotypes like migraine or tension-type headache independent of past history of primary headache have been rarely reported except few studies. [11, 12] Cough was identified as a major aggravating factor. [13] Such cases need neuroimaging to rule out possible intracranial lesions like Arnold-Chiari malformation type 1, spontaneous intracranial hypotension, carotid or vertebrobasilar diseases, middle cranial fossa or posterior fossa tumours, midbrain cyst, basilar impression, platybasia, subdural haematoma, cerebral aneurysms and reversible cerebral vasoconstriction syndrome. [4] In this study, MRI brain was not done in any patient despite sudden onset in 8 cases and aggravation by cough in 3 cases. Because headache intensity was low on visual analogue scale in most of the cases with no focal neurological deficit on examination. There was satisfactory response to symptomatic treatment. COVID protocols for imaging in hospital also increased the threshold for MRI.

Various clinical correlates have been documented so far with headache in COVID illness. Headache has been commonly reported with anosmia/ageusia, [11] younger age, fewer comorbidities and reduced mortality, as well as with low levels of C-reactive protein, mild acute respiratory distress syndrome, oropharyngeal symptoms, [14] female sex and fever. [15] Less number of positive headache patients in this study had limited us to show any particular pattern of COVID-19 associated headache, correlation of headache with various variables and effect of headache on prognosis. The second limitation of this study was inability to get brain imaging in all patients. It would have helped to rule out other secondary causes specially in current situation where cerebral thromboembolic events like ischemic stroke and cerebral venous sinus thrombosis are being frequently reported in association with COVID-19 illness. Moreover, exclusion of critically ill on ventilator patients limited us from reporting true incidence of headache in COVID illness. More data in the future will help us to better understand the headache pattern in COVID-19 patients.

Aetiology of headache during COVID pandemic can be multifactorial. But new-onset headache or change in past headache type should be considered a symptom and the threshold for COVID screening should be low in such patients even in the absence of fever and cough. Secondary headache due to COVID illness can be described as either sudden or gradual onset, mild vague aching type, mostly in temporal or frontal location, bilateral, intermittent with variable duration and evening predilection, commonly aggravated by cough and relieved by sleep.

Nil.

There are no conflicts of interest.

The prevalence of symptoms in 24

COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries

Characteristics of COVID-19 infection in Beijing

European patients with mild-to-moderate coronavirus disease

The International Classification of Headache Disorders

Chapter 2: Headache due to systemic disease

Neurological associations of COVID-19

The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence

Prevalence of headache in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 14,275 patients

Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: A web-based survey study

Mask-associated 'de novo' headache in healthcare workers during the COVID-19 pandemic

Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution

Headache characteristics in COVID-19 pandemic-a survey study

Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome?

Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: A case-control study

Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: A retrospective cohort study